Nuvectis Pharma, Inc. NVCT
- NXP900 — Non-Small Cell Lung Cancer Phase 1
- NXP900 — Renal Cell Carcinoma Phase 1
- NXP900 — Mesothelioma Phase 1
YES1 (1 companies · 3 programs)
Companies with an active program directed at YES1.
Companies with an active program directed at YES1.